Journal profile · Medicine-Medicine (all)

Serbian Journal of Experimental and Clinical Research

ISSN 1820-8665 · eISSN 2956-2090 · University of Kragujevac · Poland

Serbian Journal of Experimental and Clinical Research: fully open access; no APC; review about 6 weeks (community reports); acceptance rate 30% (journal website); 0 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ3General Medicine · rank 609/830 · 26th percentile
Review timeabout 6 weeksCommunity average
APCNo APCFully open access
Acceptance30%From the journal's website
Articles per year02025 · OpenAlex count

Scope

Aims, scope and focus

Serbian Journal of Experimental and Clinical Research is published by University of Kragujevac. By OpenAlex counts of its recent articles, its largest topics are Antioxidant Activity and Oxidative Stress, Dialysis and Renal Disease Management and Nitric Oxide and Endothelin Effects, together about 21% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

EABR. Experimental and Applied Biomedical Research former Serbian Journal of Experimental and Clinical Research is a peer-reviewed, open access journal which publishes original research articles, reviews, case reports and letters to the editor in all areas of the biomedical sciences that have not been published previously. The journal comprises both basic and clinical research in the field of biomedicine. Current acceptance rate is around 30%. EABR was founded in 2000 under the name Medicus and over more than two decades has grown into one of the leading national journals in the field of biomedical sciences. EABR. Experimental and Applied Biomedical Research is owned and published by Faculty of Medical Sciences, University of Kragujevac. The journal adheres to the policies of the International Committee of Medical Journal Editors (ICMJE) and publishing ethics guidelines provided by the Committee on Publication Ethics (COPE).EABR publishes papers from all fields of biomedical science and practice in form of original papers, short communications, reviews/meta-analyses, case reports, medical history articles, personal views, letters to the editor, reports from scientific meetings that have not been published previously. EABR is an Open Access Journal and it is published four times a year.The first issue of EABR was published in March 2000.EABR is owned and published by Faculty of Medical Sciences University of Kragujevac. However, Editors have full academic freedom and authority for determining the editorial content of the journal, according to their scientific, professional and ethical judgment.Editorial policy and decision making follow procedures which are endeavoring to ensure scientific credibility of published content, confidentiality and integrity of authors, reviewers, and review process, protection of patients’ rights to privacy and disclosing of conflict of interests.Copyright PolicyThe journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users. All articles published in EABR. Experimental and Applied Biomedical Research are published and distributed under the terms of the CC BY-NC-ND 4.0 License, hich permits reproduction, distribution, derives and commercial use, provided the original work is properly cited and authors and publisher are properly identified. After copyright assignment, copyrights to published articles are transfered tothe owner and publisher of th

From the journal's Aims & Scope

Research area (LetPub): Medicine-Medicine (all)

Editor-in-chief Olgica MihaljevicPublisher website

Editorial board by country: none in mainland China; most named Serbia 4, United States 1 (5 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Antioxidant Activity and Oxidative StressMedicine9.6%
  2. Dialysis and Renal Disease ManagementMedicine6.1%
  3. Nitric Oxide and Endothelin EffectsMedicine5.3%
  4. Metal complexes synthesis and propertiesMedicine5%
  5. Exercise and Physiological ResponsesMedicine5%
  6. Medicinal Plant ResearchAgricultural and Biological Sciences5%
  7. Cardiovascular Function and Risk FactorsMedicine4.3%
  8. Cardiac Ischemia and ReperfusionMedicine4.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
General MedicineQ3609/83026th

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
0.6LetPub ·
CiteScore (publisher)
0.6Publisher website ·
SJR 2026-06
0.12LetPub ·
SNIP 2026-06
0.14LetPub ·
h-index
15OpenAlex ·
i10-index
38OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 600 in total · the current year is incomplete

YearArticlesOpen accessCitations
20260077
202500149
202400178
202300179
20223131177
20213232173

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 6 weeksLetPub ·
Acceptance rate (publisher)
30%Publisher website ·
Peer review
Double blind peer reviewLetPub

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessLetPub

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Policy excerpts from the journal's websiteLicense & copyright
License & copyright Copyright Policy

The journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users. All articles published in EABR. Experimental and Applied Biomedical Research are published and distributed under the terms of the CC BY-NC-ND 4.0 License, hich permits reproduction, distribution, derives and commercial use, provided the original work…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
University of Kragujevac
Country or region
Poland
Language
English
ISSN
1820-8665
Print ISSN
2956-0454
Electronic ISSN
2956-2090
Official links

FAQ

Frequently asked questions about Serbian Journal of Experimental and Clinical Research

How long does peer review take at Serbian Journal of Experimental and Clinical Research?

Authors report an average review time of about 6 weeks; the journal's website gives an acceptance rate of 30%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Serbian Journal of Experimental and Clinical Research based?

Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Serbia (4) and United States (1). Counted from the institutions listed on the board page; for reference only.

Which databases index Serbian Journal of Experimental and Clinical Research?

According to LetPub and DOAJ records, Serbian Journal of Experimental and Clinical Research is indexed in Scopus.

Is Serbian Journal of Experimental and Clinical Research open access, and what is the APC?

Serbian Journal of Experimental and Clinical Research is a fully open-access journal. It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .